What is the recommended treatment for a 73-year-old male with shingles (herpes zoster) of the face?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Facial Herpes Zoster in a 73-Year-Old Male

Oral valacyclovir 1 gram three times daily for 7 days is the recommended first-line treatment for facial herpes zoster in a 73-year-old male, and should be initiated as soon as possible after diagnosis. 1, 2

First-Line Antiviral Therapy

  • Valacyclovir 1 gram three times daily for 7 days is the recommended treatment for herpes zoster in adults 2
  • Treatment should be initiated at the earliest sign or symptom of herpes zoster and is most effective when started within 48 hours of the onset of rash 2
  • Valacyclovir has better bioavailability than acyclovir, allowing for less frequent dosing and improved adherence 3
  • For facial zoster, prompt treatment is particularly important due to the risk of complications including ocular involvement 1

Alternative Antiviral Options

  • If valacyclovir is unavailable, oral acyclovir 800 mg 5 times daily for 7 days can be used 1, 3
  • Famciclovir is another alternative with similar efficacy to valacyclovir 3, 4
  • Intravenous acyclovir should be considered if the patient has disseminated or invasive disease, or is severely immunocompromised 1

Special Considerations for Facial Zoster

  • Facial zoster requires careful evaluation for potential ophthalmic involvement (herpes zoster ophthalmicus) 5
  • If there is any suspicion of eye involvement (rash on the tip or side of nose, or any ocular symptoms), urgent ophthalmology consultation is recommended 5
  • Monitor for neurological complications, which are more common with facial zoster 6
  • Consider temporary reduction in any immunosuppressive medications if the patient is on them 1

Adjunctive Therapies

  • Pain management is essential - consider acetaminophen or NSAIDs for mild pain 4
  • For moderate to severe pain, stronger analgesics may be necessary 4
  • Topical antiviral therapy is substantially less effective than systemic therapy and is not recommended 1
  • While some clinicians use corticosteroids to reduce inflammation and pain, evidence shows only modest benefits and potential risks, especially in older adults 7

Monitoring and Follow-up

  • Monitor until all lesions have scabbed over, which typically takes 2-3 weeks 1
  • Watch for secondary bacterial infection of lesions, which may require antibiotics 6
  • Follow up for development of post-herpetic neuralgia, which is more common in older adults 3
  • If post-herpetic neuralgia develops, consider tricyclic antidepressants, gabapentin, pregabalin, or topical agents like lidocaine or capsaicin 4

Prevention of Future Episodes

  • Consider recommending recombinant zoster vaccine (Shingrix) after recovery to prevent future episodes 8
  • The recombinant zoster vaccine is recommended for adults aged 50 years and older regardless of prior episodes of herpes zoster 8
  • Vaccination has been shown to reduce the incidence of herpes zoster and post-herpetic neuralgia 4

Common Pitfalls to Avoid

  • Delaying treatment beyond 72 hours reduces effectiveness, though some benefit may still be seen with later initiation 3
  • Inadequate pain management can lead to decreased quality of life and increased risk of post-herpetic neuralgia 4
  • Failure to recognize ophthalmic involvement can lead to serious complications including vision loss 5
  • Underestimating the importance of adherence to the full 7-day course of antiviral therapy 2

References

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of herpes zoster and post-herpetic neuralgia.

American journal of clinical dermatology, 2013

Guideline

Herpes Zoster Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.